Skip to content
TrialScanner

NCT06429722

To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.

Phase 2CompletedNMRALead

Registry record

Lead sponsor
Neumora Therapeutics, Inc.
Conditions
Major Depressive Episode Associated With Bipolar II Disorder
Primary completion
Apr 9, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06429722 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06429722: To Evaluate the Effects of... | TrialScanner